HM Treasury has been consulting on how to increase the flow of patient capital in the UK for innovative companies with the potential for growth into large, world-leading businesses. The Royal Society's response is based on the views of individual Fellows, particularly from those involved in the commercialisation of research and investment into technology based firms.
The response, which was also reviewed by members of the Royal Society Science, Industry and Translation Committee, mainly focuses on science and technology based companies spun out from UK universities.